NCT03132454 2025-11-03Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaM.D. Anderson Cancer CenterPhase 1 Active not recruiting32 enrolled